Table 2 Overall and cause-specific mortality by blood group in the Golestan Cohort Study
From: Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study
Blood type | number (person-years) | deaths (MR) | Overall mortality due to medical causes a | CVD mortality (number = 1,879) | Cancer mortality (number = 775) | Other medical causes (numner = 760) | |
|---|---|---|---|---|---|---|---|
crude HR (95% CI) | adjusted HR b (95% CI) | adjusted HR (95% CI) | adjusted HR (95% CI) | adjusted HR (95% CI) | |||
O | 14,971 (103,756) | 1,007 (971) | 1 | 1 | 1 | 1 | 1 |
A | 16,705 (115,764) | 1,223 (1,056) | 1.11 (1.02,1.21)* | 1.08 (1.00,1.18)* | 1.12 (1.00,1.26)* | 1.05 (0.87,1.25) | 1.03 (0.86,1.23) |
B | 13,555 (93,740) | 1,036 (1,105) | 1.12 (1.03,1.23)* | 1.09 (1.00,1.20)* | 1.15 (1.02,1.30)* | 1.14 (0.95,1.38) | 0.91 (0.75,1.10) |
AB | 4,810 (33,434) | 357 (1,068) | 1.10 (0.97,1.25) | 1.07 (0.95,1.22) | 1.16 (0.98,1.37) | 1.03 (0.79,1.35) | 0.92 (0.70, 1.21) |
Non-O | 35,070 (242,966) | 2,616 (1,077) | 1.11 (1.03,1.20)* | 1.09 (1.01,1.17)* | 1.15 (1.03,1.27)** | 1.08 (0.92,1.27) | 0.97 (0.83,1.13) |
Rh+ | 46,803 (324,155) | 3,381 (1,043) | 1 | 1 | 1 | 1 | 1 |
Rh- | 3,238 (22,553) | 242 (1,073) | 1.04 (0.91,1.19) | 1.06 (0.93,1.21) | 1.04 (0.87,1.25) | 0.88 (0.64,1.19) | 1.30 (0.99,1.69) |